A Phase 2, Randomized, Placebo-Controlled Study Evaluating Matrix Metalloproteinase-9 Inhibitor, Andecaliximab, in Patients With Moderately to Severely Active Crohn’s DiseaseStefan Schreiber, Edward V. Loftus, Corey A. Siegel et al.|Journal of Crohn s and Colitis|2018Cited by 51
Case-control study of metabolic syndrome and ovarian cancer in Chinese populationYing Chen, Ke Wang, Lei Zhang et al.|Nutrition & Metabolism|2017Cited by 35
Correction: A chemical probe of CARM1 alters epigenetic plasticity against breast cancer cell invasionXiao-Chuan Cai, Minkui Luo, Ke Wang et al.|eLife|2020Cited by 1